Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed. It focuses on bipolarity and currently lists study information in the United States.
In BelmontThis study is completed. It focuses on bipolarity and currently lists study information in Norway.
In Trondheim
This study is ongoing in Germany. It focuses on Bipolarity.
In Germany
This study is completed. It focuses on bipolarity and currently lists study information in the United States.
In PittsburghThis study is completed in the United States, in Bulgaria, in Croatia, .... It is testing asenapine for Bipolarity.
Multiple locations, including AnaheimThis study is completed in Global. It is testing asenapine Treatment for Bipolarity.
In GlobalThis study is active but not recruiting in the United States. It is testing endoxifen for Bipolarity.
Multiple locations, including CerritosThis study was terminated in Global. It is testing Eslicarbazepine Acetate (BIA 2-093) for manic episodes in bipolarity type I.
In GlobalThis study is completed in Global. It is testing Eslicarbazepine Acetate (BIA 2-093) for manic episodes in bipolarity type I.
In GlobalThis study is completed in the United States. It is testing galantamine for Bipolarity.
Multiple locations, including BostonThis study was terminated in the United States. It is testing Lu AA39959 for depression in bipolarity.
In Atlanta
This study was terminated in the United States, in Argentina, in Chile, .... It is testing ramelteon Sublingual for Bipolarity.
Multiple locations, including BirminghamHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.